Aims-Analysis of the choroidal findings in patients affected by serpiginous choroidopathy (SC). Methods-Thirteen patients (23 eyes; 11 males and two females; age range 50-68 years; mean age 59.1 years) affected by SC were examined with fluorescein angiography (FA) (BrJ Ophthalmol 1996;80:536-540) Serpiginous choroidopathy (SC) usually extends from the optic disc outwards in all directions'-'; initial spreading from the macular area is occasional and at first free of any peripapillar activity (serpiginous maculopathy).4 5SC, known also as geographic helicoid peripapillary choroidopathy' is a chronic, recurrent, progressive, usually bilateral disorder, that extends from the choroid to the retinal pigment epithelium (RPE) and ultimately to the retina. In the acute stage it is common to observe the concomitant expression of new and old lesions. The active lesions are greyish white or yellow in colour, with faint edges and are sometimes associated with a serous detachment of the neuroepithelium and/or less frequently of the RPE.6 SC can be further complicated by choroidal neovascularisation (CNV), usually occurring at the edge of an old lesion, which may represent a further cause of visual impairment in such patients. Other findings include retinal vasculitis,7 generally at the site of an active lesion and venous branch occlusion.8 The healed stage is characterised by well defined, irregularly pigmented atrophic chorioretinal areas. Visual prognosis of SC depends on the extent of foveal involvement.
ophthalmoscopic or FA evidence; (2) better identification of the active lesions which appear to be larger at the choroidal level in comparison with the corresponding retinal lesions; and (3) revealed a persistence of choroidal activity even when the signs of retinal activity had disappeared. Thus, ICGA should be a particularly useful clinical and therapeutic monitoring tool of SC. (BrJ Ophthalmol 1996; 80:536-540) Serpiginous choroidopathy (SC) usually extends from the optic disc outwards in all directions'-'; initial spreading from the macular area is occasional and at first free of any peripapillar activity (serpiginous maculopathy).4 5SC, known also as geographic helicoid peripapillary choroidopathy' is a chronic, recurrent, progressive, usually bilateral disorder, that extends from the choroid to the retinal pigment epithelium (RPE) and ultimately to the retina. In the acute stage it is common to observe the concomitant expression of new and old lesions. The active lesions are greyish white patients affected by SC (23 eyes; 11 males and two females; age 50-68 years; mean age 59.1 years): six patients (nine eyes) at the active stage viewed with ophthalmoscopy (yellow plaque at the level of the RPE) and FA, seven patients (14 eyes) at the inactive stage. The patients were followed up for 7-33 months.
All patients underwent complete ophthalmic examination: colour and red-free fundus photography, FA, and ICGA. ICGA was performed using 25 mg/patient of ICG (Cardiogreen, Hynson,Westcott and Dunning, Inc, Baltimore, MD, USA) injected into a peripheral arm vein which was followed immediately by a 5 ml flush of sterile saline via a three way stopcock. 
Results
Of the 23 eyes examined, nine presented signs of ophthalmoscopic and FA activity. In four of them we observed more than one recurrence (one case presented two recurrences, two cases three recurrences, and one case four recurrences).
FA signs of activity (early hypofluorescence with late leakage of the focus) have been well described by Schatz et al,13 Hamilton and Bird,'4 and Laatikainen and Erkkila. 5
The findings provided by ICGA in the active stage, after the observation of all recurrences, can be summarised as follows:
(1) In seven eyes we found a correspondence between ICG and FA findings, characterised by early hypofluorescent areas with late hyperfluorescence and faint edges.
(2) In 10 eyes ICGA showed in all angiographic phases an area of hypofluorescence with ill defined margins and a size greater than that seen in FA.
(3) A third pattern of activity was observed only with ICGA: a hypofluorescent area (distant from the area observed in FA) with ill defined margins in all phases (three eyes).
(4) ICGA showed, in our series, choroidal hyperfluorescence only in the late phases, after the active focus appeared to have healed when viewed with an ophthalmoscope and FA (two eyes). In these cases only ICGA revealed choroidal permeability alterations.
ICGA alsorevealed delayed choroidal filling (a time longer or equal to 8 seconds from the (Fig 1) .
(2) At the active stage, when the lesion damages the RPE and therefore becomes evident on ophthalmoscopic and FA examination (retinal stage), two ICG angiographic patterns are evident: (a) at the active stage, and in the presence of the aforementioned sign of activity (early hypofluorescence with late leakage), the ICGA reveals active areas of hypofluorescence which are similar in size, but are nevertheless usually larger compared with those observed in FA. No late hyperfluorescence is evident ( Fig  2) ; (b) occasionally the classic FA early hypofluorescence with late leakage of the active focus, corresponds to an early ICGA hypoflu- oescence with faint edges and is associated with a marked hyperfluorescence with evident diffusion in the la,-4hases. These manifestations of altered permeability of the choroidal vessels are sign of increased aggressiveness of the disease (Fig 3) .
(3) ICGA makes it possible to identify a subhealing stage characterised by activity which persists at the level of the choroid, after the focus itself appears to have healed at the level of the RPE. In such cases choroidal permeability alterations, which are usually adjacent to a recently healed focus, can be detected only by ICGA. These anomalies are characterised by a slight late diffusion without FA evidence. Systemic steroid therapy can cause the regression of such signs of choroidal activity (Fig 4) (4) The inactive or healed stage presents as an area of hypofluorescence with clearly defined margins; this hypofluorescence becomes more marked in the late phases. Within the area itself, images of greater hypofluorescence emerge indicating irregular pigmentation of the atrophic zones, together with the remaining patent choroidal vessels (Fig 5) . Note that the extension of the healed area is usually smaller than that at the active stage. After steroid therapy a reduction in the extent of the inactive hypofluorescent area compared with the initial active lesions is visible.
In the light of our observations and evidence provided by FA and ICGA we present a new classification of SC. ICGA made it possible to observe in more detail the various aspects of the disorder than did FA. In particular it allowed: (1) better staging of SC, revealing choroidal alterations without ophthalmoscopic or FA evidence; (2) In consideration of the above, ICGA could be a particularly useful tool for the clinical monitoring of SC and seems to provide a more sensitive method of investigation and appreciation of the various stages of the disorder. Moreover, the ICG angiographic signs of subclinical activity could be helpful in developing more accurate therapeutic schemes.
